Metabolic abnormalities in patients with inflammatory rheumatic diseases

作者: Patrick H. Dessein , Ahmed Solomon , Ivana Hollan

DOI: 10.1016/J.BERH.2016.10.001

关键词:

摘要: Patients with rheumatoid arthritis (RA) experience an increased cardiometabolic risk factor burden that is substantially driven by systemic inflammation. This occurs less consistently in patients ankylosing spondylitis (AS). Psoriatic most strongly associates excess adiposity and metabolic risk. RA also often have inflammation-induced proinflammatory high-density lipoprotein (HDL) cholesterol particles lean/muscle mass loss association adiposity, a condition termed cachexia, which further enhances cardiovascular The presence of HDL lean was reported AS. Individualized aerobic resistance exercise programs can improve body composition profiles Future studies should assess how long-term lifestyle changes be effectuated if these influence events inflammatory rheumatic diseases. Herein, we review the current evidence on abnormalities arthritis. We propose management strategies research agenda.

参考文章(104)
Salima Challal, Emeline Minichiello, Marie-Christophe Boissier, Luca Semerano, Cachexia and adiposity in rheumatoid arthritis. Relevance for disease management and clinical outcomes Joint Bone Spine. ,vol. 83, pp. 127- 133 ,(2016) , 10.1016/J.JBSPIN.2015.04.010
I. Hollan, P.H. Dessein, N. Ronda, M.C. Wasko, E. Svenungsson, S. Agewall, J.W. Cohen-Tervaert, K. Maki-Petaja, M. Grundtvig, G.A. Karpouzas, P.L. Meroni, Prevention of cardiovascular disease in rheumatoid arthritis Autoimmunity Reviews. ,vol. 14, pp. 952- 969 ,(2015) , 10.1016/J.AUTREV.2015.06.004
Alejandro Souto, Eva Salgado, José Ramón Maneiro, Antonio Mera, Loreto Carmona, Juan J. Gómez-Reino, Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis. Arthritis & Rheumatism. ,vol. 67, pp. 117- 127 ,(2015) , 10.1002/ART.38894
Christina Charles-Schoeman, Roy Fleischmann, Jean Davignon, Howard Schwartz, Scott M. Turner, Carine Beysen, Mark Milad, Marc K. Hellerstein, Zhen Luo, Irina V. Kaplan, Richard Riese, Andrea Zuckerman, Iain B. McInnes, Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib. Arthritis & Rheumatism. ,vol. 67, pp. 616- 625 ,(2015) , 10.1002/ART.38974
Monalyn Labitigan, Asena Bahče-Altuntas, Joel M. Kremer, George Reed, Jeff D. Greenberg, Nicole Jordan, Chaim Putterman, Anna Broder, Higher Rates and Clustering of Abnormal Lipids, Obesity, and Diabetes Mellitus in Psoriatic Arthritis Compared With Rheumatoid Arthritis Arthritis Care and Research. ,vol. 66, pp. 600- 607 ,(2014) , 10.1002/ACR.22185
Barry I Joffe, Anne E Stanwix, Milton Tobias, Martin G Veller, Kogie Reddi, Belinda A Stevens, Patrick H Dessein, Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. The Journal of Rheumatology. ,vol. 32, pp. 435- 442 ,(2005)
Silje Halvorsen, Nina K⊘pke V⊘llestad, Sella Arrestad Provan, Anne Grete Semb, Désirée van der Heijde, Kåre Birger Hagen, Hanne Dagfinrud, Cardiorespiratory Fitness and Cardiovascular Risk in Patients With Ankylosing Spondylitis: A Cross‐Sectional Comparative Study Arthritis Care and Research. ,vol. 65, pp. 969- 976 ,(2013) , 10.1002/ACR.21926
Scott M. Grundy, Metabolic syndrome update Trends in Cardiovascular Medicine. ,vol. 26, pp. 364- 373 ,(2016) , 10.1016/J.TCM.2015.10.004
Éric Toussirot, Émilie Grandclément, Béatrice Gaugler, Fabrice Michel, Daniel Wendling, Philippe Saas, Gilles Dumoulin, CBT-506, Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study Frontiers in Immunology. ,vol. 4, pp. 453- 453 ,(2013) , 10.3389/FIMMU.2013.00453